Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2009; 55(3): 37-43


O.O. Lisovyy, V.S. Nagibin, O.V. Surova, L.V Tumanovska., V.E. Dosenko, A.A. Moibenko

    O.O. Bogomoletz Institute of Physiology NationalAcademy Sciences of Ukraine, Kyiv, Ukraine


In experiments on the primary culture of isolated neonatal rat cardiomyocytes it was determined that cardiomyocytes express ALOX5 gene encoding enzyme 5-lipoxygenase. Anoxia-reoxygenation does not affect significantly the expression of 5-lipoxygenase mRNA in cardiomyocytes. Transfection of 5-lipoxygenase-specific small interfering RNA’s (siRNA) into cardiomyocytes lead to a significant reduction of 5-lipoxygenase mRNA expression in cardiomyocytes 24 hours after transfec-tion. ALOX5 gene silencing resulted in improved viability of cell population (by 13,3 % P<0,001) due to decreased number of necrotic (by 14,6 %, P<0,001), but not apoptotic, cells during anoxia-reoxygenation. Our results indicate that siRNA against ALOX5 effectively protects cardiomyocytes against anoxia-reoxygenation injury.

Keywords: Anoxia-reoxygenation, cardiomyocytes, 5-lipoxygenase mRNA


  1. Dosenko VE, Nagibin BC, Tumanovska LV etc. Postconditioning prevents apoptotic, necrotic and autophagic death of cardiomyocytes in culture . Fiziol Zh. 2005. 51. P. 12-17.
  2. Kolchin Yu.N., Popovich LF, Grabovsky LA et al. Influence of quercetin 5-lipoxygenase inhibitor on morphofunctional manifestations of myocardial damage in ischemia-reperfusion of the heart . Cardiology. 1990. 30, N 3. P. 72-75.
  3. Parkhomenko AN, Moybenko AA, Kozhukhov SN et al. The first experience with the use of intravenous form of 5-lipoxygenase inhibitor in patients with acute myocardial infarction: clinical and hemodynamic parallels, the effect of the drug on the size of necrosis . Ukr. cardiol. magazine. 2000. N 1-2. C. 5-9.
  4. Tumanovska LV, Dosenko VE, Nagibin B.C. and in. Apoptotic, autophagic and oncotic death of cardiomyocytes during anoxia-reoxygenation . Fiziol Zh. 2004. 50, N 5. P.11-18.
  5. Brash A. R. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate . J. Biol. Chem. 1999. 274. P. 23679-23682.
  6. Carol A. Sledz, Bryan R. G. Williams. RNA interference in biology and disease . Blood. 2005. 106. P. 787-794.
  7. Dosenko V.E., Nagibin V.S., Tumanovskaya L.V. et al. Proteasomal proteolysis in anoxia-reoxygenation, pre­conditioning and postconditioning of isolated cardio-myocytes . Pathophysiology. 2006. 2. P. 119-125.
  8. Duvoisin R.M., K. van Leyen, Engelhardt H., Wiedmann M. A function for lipoxygenase in pro­grammed organelle degradation . Nature. 1998. 395. P. 392-395.
  9. 9. Festjens N., Vanden Berghe T., Vandenabeele P. Ne­crosis, a well-orchestrated form of cell demise: Signal­ling cascades, important mediators and concomitant immune response . Biochim. and Biophys. Acta. 2006. 1757. P. 1371-1387.
  10. 10. Fire A., Xu S., Montgomery M.K., Kostas S. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans . Nature. 1998. 391. P.806 811.
  11. Hashimoto H., Miyazawa K., Hagiwara M. et al. Ben­eficial effects of a new 5-lipoxygenase inhibitor on occlusion- and occlusion-reperfusion-induced myocar­dial injury . Arzneimittelforschung. 1990. 40, N 2, Pt 1. P. 126-9.
  12. Heise C.E., O’Dowd B.F., Figueroa D.J. et al Characte­rization of the human cysteinyl leukotriene 2 receptor . J. Biol. Chem. 2000. 275. P. 30531-30536.
  13. Huiwen Song., Zhiyong Zhong., Lin Wong. Small in­terference RNA against PTP-1B reduces hypoxia. re-oxygenation induced apoptosis of rat cardiomyocytes . Apoptosis. 2008. 13. P. 383-393.
  14. Kamohara M., Takasaki J., Matsumoto M. et al. CysLT2 receptors on human coronary artery smooth muscle cells . Biochem. and Biophys. Res. Commun. 2001. 287. P. 1088-1092.
  15. Kuhn H., Belkner J., Wiesner R., Brash A.R. Oxygen­ation of biological membranes by the pure reticulocyte lipoxygenase . J. Biol. Chem. 1990. 265. P. 18351-18361.
  16. Liu P., Misurski D.A., Gopalakrishnan V. Cysteinyl leukotriene-dependent [Ca] responses to angiotensin II in cardiomyocytes . Amer. J. Physiol. Heart Circulat. Physiol. 2003. 284. P. 1269-1276.
  17. Lynch K.R., O’Neill G.P., Liu Q. et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor . Nature. 1999. 399. P. 789-793.
  18. Maccarrone M., Melino G., Finazzi-Agro A. Lipoxy­genases and their involvement in programmed cell death . Cell Death Differ. 2001. 8. P. 776-784.
  19. 19. Margaret A. Nordlie, Loren E. et al. Molecular as­pects of ischemic heart disease: ischemia. reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy . J. Cardiovasc. Pharmacol. Therap. 2006. 11, N 1. P. 17-30.
  20. 20. Masahiro S., Keiko T., Tomoji H., Naoki M. RNA interference targeting SHP-1 attenuates myocardial in­farction in rats . FASEB J. 2005. 19, N 14. P. 2054-2056.
  21. Murphy R. C, Gij’on M. A. Biosynthesis and me­tabolism of leukotrienes . Biochem. J. 2007. 405. P. 379-395.
  22. Nakayama H., Chen X., Baines C.P. Ca2+ and mito-chondrial-dependent cardiomyocyte necrosis as a pri­mary mediator of heart failure . J. Clin. Invest. 2007. 117, N 9. P. 2431-2444.
  23. Ogasawara H., Ishii S., Yokomizo T. et al. Charac­terization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution . J. Biol. Chem. 2002. 277. P. 18763-18768.
  24. Redmark O. Arachidonate 5-lipoxygenase . Prostag­landins & other Lipid Mediators. 2002. 68-69. P. 211-234.
  25. Reinecke H., Zhang M., Bartosek T., Charles E.M. Survival, integration, and differentiation of cardiomyo­cyte grafts . Circulation. 1999. 100. P. 193-202.
  26. Riccioni G., Capra V., D’Orazio N. et al. Leukotriene modifiers in the treatment of cardiovascular diseases . J. Leukoc. Biol. 2008. Sep. 15.
  27. Spiteller G. Are lipid peroxidation processes induced by changes in the cell wall structure and how are these processes connected with diseases? . Med. Hypoth­eses. 2003. 60, N 1. P. 69-83.
  28. Zimmermann K.C., Bonzon C, Green D.R. The ma­chinery of programmed cell death . Pharmac. Thera­peutics. 2001. 92. P. 57-70.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2022.